Evidence map›Paper›PMID 42145663›Full record

ArticleJournal of diabetes and metabolic disorders2026

Risk factors associated with prediabetes-to-diabetes conversion in a majority-minority county: a real-world analysis.

Joyce Y Lee, Ifigeneia Stathaki, Paul Gaura, Tiffany Huynh, Alexis Tran

Abstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joyce Y LeeDepartment of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, 802 W Peltason Dr (Berk Hall), Irvine, CA 92617 USA.
Ifigeneia StathakiDepartment of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, 802 W Peltason Dr (Berk Hall), Irvine, CA 92617 USA.
Paul GauraDepartment of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, 802 W Peltason Dr (Berk Hall), Irvine, CA 92617 USA.
Tiffany HuynhDepartment of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, 802 W Peltason Dr (Berk Hall), Irvine, CA 92617 USA.
Alexis TranDepartment of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, 802 W Peltason Dr (Berk Hall), Irvine, CA 92617 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To identify key risk factors associated with the progression from prediabetes to type 2 diabetes in a majority-minority county in the United States and evaluate their relative contributions. Methods: We conducted a retrospective cohort study using the deidentified EHR from the University of California, Irvine Health (2013-2023). Adults with prediabetes (confirmed by ICD codes and HbA1c values) were included, and those with diabetes of any form at baseline or with missing data were excluded. Baseline demographics and clinical factors were compared among those who progressed to T2D (converters) to those who did not (non-converters). Ordinal logistic regression and Cox proportional hazards models were used to assess predictors of conversion timing and risk. Results: A total of 2648 adults had confirmed prediabetes, of which 510 (19.3%) developed T2D. Among converters, 81.6% progressed within 5 years of the initial prediabetes diagnosis. The two groups were similar at baseline, except converters had higher obesity rates and were more likely to have Hispanic/Latino ethnicity ( Conclusions: Elevated HbA1c and triglycerides at baseline were associated with early conversion to T2D. This study underscores the need for early, targeted intervention in individuals with high-risk ethnic and clinical profiles to stop T2D.

Indexed as

Big dataPrediabetesProgressionRisk factorsType 2 diabetes

Identifiers

PMID42145663
PMCPMC13172138

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.